D 75N95022Q00081_RFQ.pdf

RFQ No. 75N95022Q00081

NON-COMPETITIVE

COMBINED SYNOPSIS / SOLICITATION

75N95022Q00081

Title: Induced Pluripotent Stem (iPS) Cell-Derived Differentiated Cells

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.

(ii) The solicitation number is 75N95022Q00081 and the solicitation is issued as a request for quotation (RFQ).

This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures;

FAR Subpart 13.5— Simplified Procedures for Certain Commercial Items; and FAR Part 12—Acquisition of Commercial Items, and is expected to exceed the simplified acquisition threshold. The Government anticipates award of a firm fixed-price purchase order for this acquisition, and the anticipated award date is February 10, 2022.

(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2022-02 effective January 14, 2022.

(iv) This acquisition has no set-aside restrictions. The associated NAICS code is 325414 and the small business size standard is 1,250 employees.

THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS

SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT

PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).

The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to Fujifilm Cellular Dynamics, Inc., 465 Science Drive, Madison, Wisconsin 53711-1074 for induced pluripotent stem (iPS) cell-derived differentiated cells. NCATS has been using this vendor’s neuronal cells and endothelial cells for the biofabrication of 3D tissue models and it is critical to continue using this vendor’s cells to keep uniform data going forward and avoid variables that could skew results.

This acquisition is conducted as non-competitive for a commercial item or service and is conducted pursuant to FAR Subpart 13.5—Simplified Procedures for Certain

Commercial Items and FAR 13.501, Special Documentation Requirements, in accordance with 41 United States Code (U.S.C.) 1901.

DESCRIPTION

(v) This acquisition is for the following items:

Product No.

Description Qty

R1092 iCell Astrocytes Kit, 01434 47 R1032 iCell DopaNeurons, 01279 13 C1028 iCell DopaNeurons, 01279 [CELL ONLY] 20 M1019 iCell Endothelial Cells Medium Supplement 50 C1175 iCell GABANeurons (APOE 4/4), 01434 [CELL ONLY] 18 R1011 iCell GABANeurons Kit, 01279 13 R1013 iCell GABANeurons, 01434 8 C1008 iCell GABANeurons, 01279 [CELL ONLY] 15 R1034 iCell GlutaNeurons, 01279 13 C1060 iCell GlutaNeurons, 01279 [CELL ONLY] 5 C1033 iCell GlutaNeurons, 01279 [CELL ONLY] 15 R1101 iCell Retinal Pigment Epithelial Cells Kit, 01279 30 C1113 MyCell DopaNeurons, 01279 [CELL ONLY] 14 C1112 MyCell DopaNeurons, 01279 [CELL ONLY] 9

(vi) Delivery shall be made to the following location, FOB Destination:

The National Center for Advancing Translational Sciences (NCATS) 9800 Medical Center Drive Rockville, MD 20850

Delivery will be in four (4) separate shipments tentatively scheduled to occur on the below dates. The tentative shipment schedule, including how much of which items are to be in each shipment, is attached.

1. February 15, 2022

2. March 1, 2022

3. March 15, 2022

4. April 1, 2022

EVALUATION AND AWARD

(vii) The anticipated award date is February 10, 2022.

(viii) The Government plans to award a fixed-price purchase order resulting from this solicitation. The resulting award will be made to Fujifilm Cellular Dynamics, Inc. as long as it is technically acceptable and at a fair and reasonable price. If additional quotations are received, the award will be made to the vendor who represents the best value to the Government, price and other factors considered. The Government will use comparative evaluations to determine which quotation is the best value, in consideration of the following evaluation criteria: Technical Capability, Past Performance, and Price.

SUBMISSION INSTRUCTIONS

(ix) All responses to this RFQ must be received by 9:00am Eastern Time on February 8, 2022 and must reference the solicitation number cited above. Responses must be submitted via email to Kimberly Espinosa at kimberly.espinosa@nih.gov.

(x) This is an RFQ. This request does not commit the Government to pay any costs incurred in the preparation of the submission of this quotation or to contract for supplies or service. Any representations and/or certifications attached to this RFQ must be completed by the quoter.

(xi) Responses to this RFQ must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product or service. Responses may exceed capability or performance characteristics of the solicitation's requirements. The Government reserves the right, but is not required, to award to a response that exceeds capability or performance characteristics of the solicitation's requirements if it provides a benefit to the Government.

(xii) Responses must also include the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), the certification of business size, the completed FAR Provisions 52.225-2 and 52.229-11 (both attached), and a quotation that includes:

1. The total price (inclusive of all costs, fees, shipping, etc.),

2. Individual prices for each listed line item,

3. Prompt payment discount terms,

4. Product or catalog number(s),

5. Product/service description, and

6. Any other information or factors that may be considered in the award decision. Such factors may include: special features required for effective program performance;

trade-in considerations; probable life of the item selected as compared with that of a comparable item; warranty considerations; maintenance availability; and environmental and energy efficiency considerations.

(xiii) For information about this RFQ, contact Kimberly Espinosa, Contracting Officer, at 301- 827-3546 or kimberly.espinosa@nih.gov.

mailto:kimberly.espinosa@nih.gov

(xiv) All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.

TERMS AND CONDITIONS, PROVISIONS, AND REPRESENTATIONS

(xv) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998). This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at www.acquisition.gov.

The following provisions apply to this acquisition and are incorporated by reference:

1. FAR 52.204-7, System for Award Management (Oct 2018)

2. FAR 52.204-16, Commercial and Government Entity Code Reporting (Aug 2020)

3. 52.212-3, Offeror Representations and Certifications—Commercial Items (Nov 2020)

4. FAR 52.214-34, Submission of Offers in the English Language (Apr 1991)

5. FAR 52.214-35, Submission of Offers in U.S. Currency (Apr 1991)

6. FAR 52.229-11, Tax on Certain Foreign Procurements – Notice and Representation (

(xvi) The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998). This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at www.acquisition.gov.

In addition to the clauses checked in FAR 52.212-5 (attached), the following clauses also apply to this acquisition and are incorporated by reference:

1. FAR 52.204-13, System for Award Management Maintenance (Oct 2018)

2. FAR 52.204-18, Commercial and Government Entity Code Maintenance (Aug 2020)

3. FAR 52.212-4, Contract Terms and Conditions – Commercial Items (Oct 2018)

4. HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity

Investigations (December 18, 2015)

(xvii) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement.

ATTACHMENTS

(xviii) The following are attached in full text:

1. Tentative Shipment Schedule

2. The provision at FAR 52.212-1, Instructions to Offerors – Commercial Items (Nov

2021) (Tailored)

3. The provision at FAR 52.225-2, Buy American Certificate (Feb 2021)

4. The provision at FAR 52.229-11, Tax on Certain Foreign Procurements—Notice and

Representation (Jun 2020)

5. The clause at FAR 52.212-5, Contract Terms and Conditions Required to Implement

Statutes or Executive Orders–Commercial Items (Jan 2022)

6. NIH Invoice and Payment Provisions and Electronic Invoicing Instructions (Feb 2021)